Related Experiment Video
Updated: Oct 17, 2025
10:33
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
2.9K
Overview: Mycobacterium ulcerans Disease (Buruli Ulcer)
Katharina Röltgen1, Gerd Pluschke2,3,4
1Department of Pathology, Stanford School of Medicine, Stanford University, Stanford, CA, USA. roeltgen@stanford.edu.
Methods in Molecular Biology (Clifton, N.J.)
|October 13, 2021
Summary
International research has advanced understanding of Mycobacterium ulcerans infections, leading to improved diagnostics and cultivation methods. Key questions remain regarding transmission and host-pathogen interactions for Buruli ulcer (BU).
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- International research efforts, spurred by the Global BU Initiative, have significantly advanced the understanding of Mycobacterium ulcerans infections.
- Improved cultivation techniques for this slow-growing pathogen enable comprehensive studies on its epidemiology and pathogenesis.
- The Global BU Initiative, established by the WHO in 1998, has been pivotal in coordinating global research.
Purpose of the Study:
- To summarize advancements in understanding Mycobacterium ulcerans infections.
- To highlight the development of diagnostic tools and research methodologies.
- To identify remaining critical research questions.
Main Methods:
- Genomic and proteomic analysis of M. ulcerans isolates.
- In vitro and animal model studies of host-pathogen interactions.
- Development of diagnostic tests utilizing specific genomic sequences.
- Drug susceptibility testing of M. ulcerans.
Main Results:
- Enhanced understanding of M. ulcerans epidemiology and pathogenesis.
- Successful cultivation of the pathogen from Buruli ulcer lesions.
- Identification of target sequences for diagnostic assay development.
- Insights into host-pathogen interactions and drug susceptibility.
Conclusions:
- Significant progress has been made in studying Mycobacterium ulcerans, including diagnostics and cultivation.
- Research has elucidated aspects of M. ulcerans genomics, proteomics, and drug susceptibility.
- Further research is crucial to understand environmental reservoirs, transmission dynamics, and host-pathogen interactions influencing disease outcomes.
Related Concept Videos
01:28Pulmonary Tuberculosis II
652
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
652
01:31Pulmonary Tuberculosis III
520
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
520
01:28Pulmonary Tuberculosis V
267
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
267
01:28Peptic Ulcer Disease II: Pathophysiology
1.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.1K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
416
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
416
01:30Peptic Ulcer Disease I: Introduction
331
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
331